என்சைன் ப்ரொஃபெஸர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from என்சைன் ப்ரொஃபெஸர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In என்சைன் ப்ரொஃபெஸர் Today - Breaking & Trending Today

Immunocore Holdings Limited: Immunocore Reports First Quarter 2021 Financial Results


Immunocore Holdings Limited: Immunocore Reports First Quarter 2021 Financial Results
Launched
includes
$287 million in net proceeds from initial public offering and concurrent private placement in February 2021
Holdings Plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announced its results for the quarter ended March 31, 2021.
Highlights for the quarter included the presentation of the Phase 3 randomized data from the Company s lead candidate tebentafusp in the plenary clinical trial session at the American Association for Cancer Research (AACR) Annual Meeting, the launch of a global early access program for tebentafusp, and the successful completion of the Company s initial public offering resulting in net proceeds of $287 million. ....

United States , Bahija Jallal , Debra Nielsen , Clayton Robertson , Roys Herbst , Exchange Commission On , Meeting Library , Melinda Gates Foundation , Company Annual Report On Form , Translational Research At Yale Cancer Center , Head Of Communications , American Society Of Oncology , Company Phase , Company Board Of Directors , Drug Administration , Cancer Center , Exchange Commission , Holdings Plc Nasdaq , American Association For Cancer Research , Consilium Strategic Communications , Reports First Quarter , License Application , American Association , Cancer Research , Annual Meeting , Chief Executive Officer ,

Immunocore Limited: Immunocore announces key appointments to management and Board


Immunocore Limited: Immunocore announces key appointments to management and Board
Ralph Torbay appointed Head of Commercial to spearhead the launch of tebentafusp
Dr. Roy S. Herbst appointed as a Non-Executive Director to the Board
OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US - 16 February 2021 - Immunocore Holdings plc (Nasdaq: IMCR), (or the Company or Immunocore ), a late-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infectious and autoimmune disease, today announces the appointment of Ralph Torbay as its new Head of Commercial and the appointment of Dr. Roy S. Herbst as a member of its Board of Directors, effective January 28, 2021. ....

United States , Immunocore Rockville , Ralph Torbay , Bahija Jallal , Debra Nielsen , Clayton Robertson , Roy Herbst , Roys Herbst , National Cancer Institute , Company Or Immunocore , Shanghai Junshi Biosciences Co Ltd , University Of Rochester , Translational Research At Yale Cancer Center , Thoracic Malignancy Steering Committee , Rochester Institute Of Technology , Head Of Communications , Simon Graduate School Of Business , Cancer Center , Master Of Business Administration , American Association For Cancer Research , Immunocore Holdings , Consilium Strategic Communications , Non Executive Director , Global Haematology Head , Novartis Oncology , Business Administration ,